In pursuit of validating PRMT3's involvement in neoadjuvant chemoradiation resistance in rectal cancer, we generated several rectal cancer patient‐derived organoid lines (PDO) which develops a dense 3D morphology (Figure 1D). Here, PRMT3 is linked to rectal cancer.